Identification of Potential Sites for Tryptophan Oxidation in Recombinant Antibodies Using tert-Butylhydroperoxide and Quantitative LC-MS

• Miriam Hensel,

  Affiliation Pharma Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Rebecca Steurer,

  Affiliation Pharma Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Juergen Fichtl,

  Affiliation Pharma Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Carsten Elger,

  Affiliation Pharma Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Frank Wedekind,

  Affiliation Pharma Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Andreas Petzold,

  Affiliation Pharma Research Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Tilman Schlothauer,

  Affiliation Pharma Research Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Michael Molhoj,

  Affiliation Pharma Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Dietmar Reusch,

  Affiliation Pharma Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Patrick Bulau

  * E-mail: patrick.bulau@roche.com

  Affiliation Pharma Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany

  ⨯